Yafei Shi

1.4k total citations
66 papers, 1.0k citations indexed

About

Yafei Shi is a scholar working on Molecular Biology, Behavioral Neuroscience and Biological Psychiatry. According to data from OpenAlex, Yafei Shi has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Behavioral Neuroscience and 11 papers in Biological Psychiatry. Recurrent topics in Yafei Shi's work include Stress Responses and Cortisol (12 papers), Tryptophan and brain disorders (11 papers) and Lung Cancer Treatments and Mutations (9 papers). Yafei Shi is often cited by papers focused on Stress Responses and Cortisol (12 papers), Tryptophan and brain disorders (11 papers) and Lung Cancer Treatments and Mutations (9 papers). Yafei Shi collaborates with scholars based in China, United States and Hong Kong. Yafei Shi's co-authors include Yantao Wei, Huang Yao, Donghui Pan, Rong Zhang, Shasha Bai, Kerun Cao, Min Qiu, Yanyan Wu, Yicheng Jiang and Chunyu Li and has published in prestigious journals such as ACS Nano, The Science of The Total Environment and Nutrients.

In The Last Decade

Yafei Shi

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yafei Shi China 17 331 150 142 134 125 66 1.0k
Sulei Wang China 13 308 0.9× 71 0.5× 43 0.3× 17 0.1× 54 0.4× 28 760
Tianyuan Ye China 17 411 1.2× 104 0.7× 10 0.1× 25 0.2× 34 0.3× 37 882
Aidong Chen China 22 430 1.3× 16 0.1× 18 0.1× 32 0.2× 98 0.8× 62 1.3k
Xiaolin Zhang China 16 352 1.1× 36 0.2× 11 0.1× 20 0.1× 38 0.3× 56 928
Shikha Prasad United States 15 633 1.9× 67 0.4× 24 0.2× 7 0.1× 58 0.5× 35 1.5k
Qiaofeng Wu China 22 430 1.3× 90 0.6× 7 0.0× 21 0.2× 53 0.4× 101 1.3k
Toshio Kumai Japan 28 641 1.9× 46 0.3× 5 0.0× 97 0.7× 129 1.0× 118 2.1k

Countries citing papers authored by Yafei Shi

Since Specialization
Citations

This map shows the geographic impact of Yafei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yafei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yafei Shi more than expected).

Fields of papers citing papers by Yafei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yafei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yafei Shi. The network helps show where Yafei Shi may publish in the future.

Co-authorship network of co-authors of Yafei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yafei Shi. A scholar is included among the top collaborators of Yafei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yafei Shi. Yafei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yaxin, et al.. (2025). Dual Graph Attention Networks for Multi-View Visual Manipulation Relationship Detection and Robotic Grasping. IEEE Transactions on Automation Science and Engineering. 22. 13694–13705.
2.
Cao, Kerun, Shasha Bai, Yafei Shi, et al.. (2025). Glutamate-mediated antidepressant effects of Jieyu I formula via modulation of PFCCaMKII-LHbCaMKII/GABA circuitry in lipopolysaccharide-induced depression model. Journal of Ethnopharmacology. 342. 119414–119414. 3 indexed citations
4.
Song, Yue, Yu Jiang, Mei Xu, et al.. (2025). Fangchinoline-mediated autophagy inhibition amplifies antigen presentation and PD-1 blockade efficacy in lung cancer. Acta Pharmacologica Sinica. 46(10). 2751–2764. 2 indexed citations
5.
Guo, Junjun, Jie Min, Junwei Shi, et al.. (2024). Stabilizing Lead Halide Perovskites via an Organometallic Chemical Bridge for Efficient and Stable Photovoltaics. ACS Nano. 8 indexed citations
7.
Zhou, Rui-Sheng, et al.. (2024). Mechanistic insights into Yifei Sanjie pill's regulation of EMT to enhance gefitinib treatment effect in NSCLC by in silico analysis and experimental validation. Journal of Ethnopharmacology. 334. 118343–118343. 3 indexed citations
8.
Ye, Lihong, Shasha Bai, Lei Yang, et al.. (2023). Si-Ni-San alleviates early life stress-induced depression-like behaviors in adolescence via modulating Rac1 activity and associated spine plasticity in the nucleus accumbens. Frontiers in Pharmacology. 14. 1274121–1274121. 6 indexed citations
9.
Li, Qiuyue, et al.. (2022). The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma. Evidence-based Complementary and Alternative Medicine. 2022. 1–16. 5 indexed citations
11.
Yang, Lei, et al.. (2021). Depression promotes lung carcinoma progression by regulating the tumor microenvironment in tumor-bearing models of C57BL/6J mice. Neuroscience Letters. 754. 135851–135851. 12 indexed citations
13.
Shi, Yafei, Wei Chen, Chunyu Li, et al.. (2020). Clinicopathological characteristics and prediction of cancer-specific survival in large cell lung cancer: a population-based study. Journal of Thoracic Disease. 12(5). 2261–2269. 10 indexed citations
14.
Zhou, Xiaowei, Ying Li, Mingyu Zhang, et al.. (2019). Spectrum-Effect Relationship between UPLC Fingerprints and Antilung Cancer Effect of Si Jun Zi Tang. Evidence-based Complementary and Alternative Medicine. 2019. 1–9. 16 indexed citations
15.
Chen, Wei, et al.. (2019). Pharmacokinetic Study and Tissue Distribution of Lorlatinib in Mouse Serum and Tissue Samples by Liquid Chromatography-Mass Spectrometry. Journal of Analytical Methods in Chemistry. 2019. 1–10. 8 indexed citations
16.
Xiang, Xiaoli, et al.. (2019). Cilostazol Promotes Angiogenesis and Increases Cell Proliferation After Myocardial Ischemia–Reperfusion Injury Through a cAMP-Dependent Mechanism. Cardiovascular Engineering and Technology. 10(4). 638–647. 22 indexed citations
17.
Li, Chunyu, Ming Niu, Ruilin Wang, et al.. (2019). The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach. Biomedicine & Pharmacotherapy. 111. 1132–1140. 27 indexed citations
18.
Chen, Wei, Jun Yang, Huiling Wang, et al.. (2018). Discovering Associations of Adverse Events with Pharmacotherapy in Patients with Non-Small Cell Lung Cancer Using Modified Apriori Algorithm. BioMed Research International. 2018. 1–10. 8 indexed citations
19.
Shi, Yafei & Wenzhu Wang. (2018). Application of different anesthetic methods in coronary artery bypass grafting and the effect on postoperative outcome. Experimental and Therapeutic Medicine. 17(1). 695–700. 8 indexed citations
20.
Li, Yan, et al.. (2001). Discussion on Experimental Study on Qiqing Theory. Zhongguo zhongyi jichu yixue zazhi. 7(10). 11–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026